In collaboration with the International Agency for Research on Cancer (IARC, Lyon France) we initiated a pilot study at five sites Latin American (Mexico, Costa Rica, Colombia (2), Chile) to assess risk factors and molecular signatures for premenopausal breast cancer in Latinas. Future studies will expand the cohort at all sites and will compare data from this Latin American study with US studies.
